Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-23-003071

Director acquired 7,867 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
OLUKOTUN ADEOYE Y Director 2023-01-10 Grant or award +7,867 19,217 D
Derivatives
OLUKOTUN ADEOYE Y Director 2023-01-10 Grant or award · Common Stock +4,593 4,593 D
Loading xslF345X03/doc4.xml…